Skip to content
Vasundhara Rasayans logo

Vasundhara Rasayans

538634 BSE
Price unavailable

Vasundhara Rasayans (VRL) share price was ₹137.00 at the 28 Oct 2026 close; market capitalisation ₹43.57 Cr; P/E (TTM) 7.37; sector Healthcare. The share price fell 19.9% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 8.3% year on year to ₹6.93 Cr and net profit was ₹0.65 Cr, against ₹0.57 Cr a year earlier (compared with Jun 2025). Promoters held 61.98% of Vasundhara Rasayans in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 60/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹137.00 −33.75 −19.77% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹43.57 Cr
P/E (TTM)
7.37
EBITDA
₹8.70 Cr
Return on Equity
14.16%
Debt to Equity
0.04
Book Value
₹128.61
EPS (TTM)
₹18.60
52W High
₹220.00
52W Low
₹100.10

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,766.5035.044,23,843 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,631.0087.412,55,673 Cr15.250.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,596.5072.161,74,836 Cr9.520.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,183.50107.881,17,977 Cr22.260.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,180.9026.281,17,795 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,340.8034.731,11,914 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,370.8032.841,10,741 Cr3.130.96%11.21%14.88%28,589 Cr3,356 Cr
Vasundhara Rasayans (this company)
—7.3744 Cr1.071.43%14.16%20.02%2,294 Cr6 Cr
Median 8 companies₹1,766.5034.891,17,886 Cr4.710.72%13.98%18.45%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

60 Good
Overall score

Data confidence 100/100

Category scores

Quality Good 61
Returns, margins, earnings quality 22% weight
Valuation Strong 79
Cheap vs sector & own history 24% weight
Growth Weak 41
Sales & profit trajectory 9% weight
Financial Health Good 63
Solvency, leverage, coverage 9% weight
Momentum Average 54
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 1.17 times its book value

Weaknesses

3
  • The company has delivered a poor sales growth of 9.51% over past five years.
  • Earnings include an other income of Rs.2.59 Cr.
  • Debtor days have increased from 60.7 to 76.2 days.

Technical Indicators

Oscillators

Bullish

Bearish
1
Neutral
6
Bullish
2

Overall

Bearish

Bearish
11
Neutral
6
Bullish
2

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
6.34% higher than 3Y

change over 1 year

Net Income Growth
38.1% higher than 3Y

change over 1 year

Cash Flow Change
72.9%

change over 1 year

EBITDA Margin Change
27.97%

change over 1 year Operating margin 9.96% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
8.33
9.32
8.23
11.14
7.63
9.78
8.82
7.76
7.56
8.82
7.45
11.89
6.93
Expenses
7.36
7.62
6.77
8.87
6.77
8.16
7.25
7.75
7.23
6.7
6.94
9.05
6.24
Operating Profit
0.97
1.7
1.46
2.27
0.86
1.62
1.57
0.01
0.33
2.12
0.51
2.84
0.69
OPM %
11.64%
18.24%
17.74%
20.38%
11.27%
16.56%
17.8%
0.13%
4.37%
24.04%
6.85%
23.89%
9.96%
Other Income
0.42
0.27
0.5
0.74
0.45
0.53
0.54
0.83
0.68
0.86
0.67
0.69
0.37
Interest
0.06
0.03
0.01
0.07
0.06
0.08
0.06
0.08
0.14
0.09
0.1
0.08
0.05
Depreciation
0.04
0.06
0.08
0.08
0.08
0.09
0.09
0.1
0.1
0.11
0.11
0.11
0.13
PBT
1.29
1.88
1.87
2.86
1.17
1.98
1.96
0.66
0.77
2.78
0.97
3.34
0.88
Tax %
26.36%
26.06%
26.2%
25.52%
25.64%
26.26%
26.02%
31.82%
25.97%
25.9%
25.77%
25.75%
26.14%
Net Profit
0.96
1.39
1.38
2.13
0.86
1.47
1.45
0.45
0.57
2.06
0.72
2.48
0.65
EPS (₹)
3.02
4.37
4.34
6.7
2.71
4.63
4.56
1.42
1.79
6.48
2.27
7.8
2.05
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
18.4
15.27
15.41
16.58
19.71
21.17
22.68
26.7
37.88
36.96
33.99
35.72
35.09
Expenses
16.8
13.97
13.76
14.78
18.55
18.33
19.57
24.49
32.32
30.53
29.88
29.88
28.93
Operating Profit
1.6
1.3
1.65
1.8
1.16
2.84
3.11
2.21
5.56
6.43
4.11
5.84
6.16
OPM %
8.7%
8.51%
10.71%
10.86%
5.89%
13.42%
13.71%
8.28%
14.68%
17.4%
12.09%
16.35%
17.55%
Other Income
0.31
0.25
0.44
7.74
1.04
1.15
0.99
1.04
2.3
1.94
2.35
2.9
2.59
Interest
0.53
0.57
0.39
0.17
0.08
0.06
0.09
0.09
0.25
0.21
0.34
0.45
0.32
Depreciation
0.5
0.56
0.56
0.32
0.05
0.03
0.05
0.12
0.13
0.26
0.36
0.43
0.46
PBT
0.88
0.42
1.14
9.05
2.07
3.9
3.96
3.04
7.48
7.9
5.76
7.86
7.97
Tax %
34.09%
45.24%
59.65%
28.07%
29.95%
23.59%
25.76%
28.62%
25.27%
25.82%
26.39%
26.46%
—
Net Profit
0.58
0.24
0.46
6.52
1.45
2.99
2.94
2.17
5.59
5.86
4.25
5.79
5.91
EPS (₹)
1.82
0.76
1.45
20.51
4.56
9.41
9.25
6.83
17.59
18.44
13.37
18.22
18.6
Div. Payout %
27.41%
0%
69.13%
4.88%
21.93%
15.95%
16.22%
14.65%
0%
0%
14.96%
10.98%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.18
3.18
3.18
3.18
3.18
3.18
3.18
3.18
3.18
3.18
3.18
3.18
Reserves
3.72
3.96
4.04
10.56
11.63
14.23
16.69
18.36
23.64
28.76
32.38
37.7
Borrowings
5.58
5.01
3.1
1.41
0.46
0
0
1.31
4.02
1.95
4.21
1.81
Other Liabilities
4.16
3.21
3.13
5.23
5.56
7.28
3.14
2.66
3.68
3.41
3.3
5.19
Total Liabilities
16.64
15.36
13.45
20.38
20.83
24.69
23.01
25.51
34.52
37.3
43.07
47.88
Fixed Assets
7.62
7.28
6.78
0.1
0.2
0.3
0.67
0.91
0.86
2.43
2.49
2.35
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.23
0.18
0.07
1.1
1.23
0.97
1.12
0.32
0
1.16
2.35
2.51
Other Assets
8.79
7.9
6.6
19.18
19.4
23.42
21.22
24.28
33.66
33.71
38.23
43.02
Total Assets
16.64
15.36
13.45
20.38
20.83
24.69
23.01
25.51
34.52
37.3
43.07
47.88
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1.56
1.32
2.42
-10.7
0.43
0.36
0.22
7.9
-6.5
6.03
-5.83
-1.58
Investing
-2.02
-0.06
0.07
13.3
0.53
1.02
0.16
1.39
1.27
-1.32
0.46
2.01
Financing
0.46
-1.28
-2.24
-2.26
-1.36
-0.87
-0.49
0.79
2.19
-2.88
1.35
-3.44
Net Cash Flow
0
-0.01
0.24
0.33
-0.41
0.5
-0.12
10.08
-3.04
1.83
-4.02
-3.01
Free Cash Flow
-0.5
1.1
2.38
3.34
0.29
0.23
-0.2
7.55
-6.58
4.2
-6.25
-1.88
CFO/OP
117
114
164
-457
153
36
51
397
-95
125
-78
-13
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
74.39
93.22
89.53
132
94.63
107
99.3
100
77.57
61.43
44.56
76.23
Inventory Days
45.71
53.9
69.11
64.32
60.51
59
48.01
57.91
79.48
38.86
44.33
36.74
Days Payable
59.78
31.68
52.91
62.28
45.28
59.39
76.61
57.65
48.68
40.43
42.91
67.68
Cash Conversion Cycle
60.32
115
106
134
110
107
70.7
101
108
59.85
45.98
45.29
Working Capital Days
11.9
12.43
14.69
259
246
267
144
128
175
194
274
344
ROCE %
12.04%
8.04%
13.44%
14.21%
14.14%
23.75%
21.73%
12.92%
28.79%
25.06%
16.56%
20.16%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vasundhara Rasayans insights

64 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

Promot.61.98%Others7.35%Public30.67%As ofSep 2026

Documents

Frequently Asked Questions about Vasundhara Rasayans

What does Vasundhara Rasayans Ltd do?
Incorporated in 1987, Vasundhara Rasayans Ltd is a manufacturer and exporter of Antacids[1]
Where is Vasundhara Rasayans Ltd (VRL) listed?
Vasundhara Rasayans Ltd trades under code 538634 on the BSE.
Which sector does Vasundhara Rasayans Ltd belong to?
Vasundhara Rasayans Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Vasundhara Rasayans Ltd?
Vasundhara Rasayans Ltd has a market capitalisation of ₹43.57 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Vasundhara Rasayans Ltd?
Vasundhara Rasayans Ltd trades at a PE ratio of 7.37 as of 28 Oct 2026, on earnings per share of ₹18.6, against a book value of ₹128.61 per share.
What is the 52-week high and low of Vasundhara Rasayans Ltd?
Over the last 52 weeks Vasundhara Rasayans Ltd has traded between ₹100.1 and ₹220 as of 28 Oct 2026.
Does Vasundhara Rasayans Ltd pay dividends?
Vasundhara Rasayans Ltd has a dividend yield of 1.46%.
What is the Return on Equity (ROE) of Vasundhara Rasayans Ltd?
Vasundhara Rasayans Ltd reported a return on equity of 14.16%. Its debt-to-equity ratio is 0.04.

Company Information

Incorporated in 1987, Vasundhara Rasayans Ltd is a manufacturer and exporter of Antacids[1]

Website vrlindia.in
Face Value ₹ 10
Shares Outstanding 31,80,451

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/538634.md for Vasundhara Rasayans Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month